Artelo Biosciences Inc. (NASDAQ: ARTL) Starts Presentation at 12th Annual LD Micro Main Event
Artelo Biosciences (NASDAQ: ARTL) is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. The company’s programs have the potential to dramatically improve patient care in major markets. Artelo’s science-based approach rests on three pillars that uniquely position the company for growth: an unwavering dedication to letting the science lead; a portfolio-based, de-risked and nimble business strategy; and an experienced leadership team with proven performance in regulated drug development and global commercialization. For more information, visit…







